Influenza News and Research RSS Feed - Influenza News and Research

Influenza (the flu) is a contagious respiratory illness caused by influenza viruses. It can cause mild to severe illness, and at times can lead to death. The best way to prevent the flu is by getting a flu vaccination each year. Every year in the United States, on average 5% to 20% of the population gets the flu; more than 200,000 people are hospitalized from flu complications, and; about 36,000 people die from flu-related causes. Some people, such as older people, young children, and people with certain health conditions, are at high risk for serious flu complications.
NanoViricides' anti-viral drug candidates show promise in lethal animal model of dermal herpes infection

NanoViricides' anti-viral drug candidates show promise in lethal animal model of dermal herpes infection

NanoViricides, Inc., a nanomedicine company developing anti-viral drugs, discusses the significance of the strong effectiveness demonstrated by its anti-viral drug candidates in a lethal animal model of dermal herpes infection. [More]
WHO: Progress towards global vaccination targets 'far off track'

WHO: Progress towards global vaccination targets 'far off track'

Progress towards global vaccination targets for 2015 is far off track with 1 in 5 children still missing out on routine life-saving immunizations that could avert 1.5 million deaths each year from preventable diseases. In the lead-up to World Immunization Week 2015 (24 -30 April), the World Health Organization is calling for renewed efforts to get progress back on course. [More]
Cardiff scientists make breakthrough asthma discovery

Cardiff scientists make breakthrough asthma discovery

Cardiff University scientists have for the first time identified the potential root cause of asthma and an existing drug that offers a new treatment. [More]
Cardiff scientists identify potential root cause of asthma and highlight new treatment option

Cardiff scientists identify potential root cause of asthma and highlight new treatment option

Cardiff University scientists have for the first time identified the potential root cause of asthma and an existing drug that offers a new treatment. [More]
New study sheds light on mechanism that affects AID enzyme

New study sheds light on mechanism that affects AID enzyme

A new study by immunology researchers at the IRCM led by Javier M. Di Noia, PhD, sheds light on a mechanism affecting AID, a crucial enzyme for the immune response. The scientific breakthrough, published in the latest issue of The Journal of Experimental Medicine, could eventually improve the way we treat the common flu, as well as lymphoma and leukemia. [More]
International science team pave way for fast and accurate diagnosis of the influenza virus

International science team pave way for fast and accurate diagnosis of the influenza virus

Statistics indicate that, on average, adults over the age of 30 only contract the influenza virus twice in a decade – but far more frequently (self) misdiagnose a cold virus (commonly rhinovirus or coronavirus) as being the flu... [More]
Research findings could bolster efforts to develop next gen of anti-viral treatments

Research findings could bolster efforts to develop next gen of anti-viral treatments

A newly developed spectroscopy method is helping to clarify the poorly understood molecular process by which an anti-HIV drug induces lethal mutations in the virus's genetic material. [More]
Focus Diagnostics announces FDA clearance for Simplexa Group A Strep Direct Kit

Focus Diagnostics announces FDA clearance for Simplexa Group A Strep Direct Kit

Focus Diagnostics, the clinical-laboratory products business of Quest Diagnostics, today announced the FDA 510(k) clearance and CLIA moderate-complexity categorization for its Simplexa Group A Strep Direct Kit. Simplexa Group A Strep Direct is a real-time polymerase chain reaction assay for the detection of Group A Streptococcus bacteria directly from throat swabs. [More]
Johns Hopkins researchers named recipients of Hartwell’s 2014 Individual Biomedical Research Award

Johns Hopkins researchers named recipients of Hartwell’s 2014 Individual Biomedical Research Award

Gul Dolen, M.D., Ph.D., an assistant professor of neuroscience at the Johns Hopkins University School of Medicine, and Eili Y. Klein, Ph.D., an assistant professor of emergency medicine, are among 12 recipients of The Hartwell Foundation’s 2014 Individual Biomedical Research Award competition, the foundation announced on April 1. [More]
Simple, effective portable tool can help predict avian flu outbreaks

Simple, effective portable tool can help predict avian flu outbreaks

A simple and effective portable tool to predict avian flu outbreaks on farms has been created by University of Guelph researchers. [More]
UofL-led study focuses on flu vaccine for children with neurological disorders

UofL-led study focuses on flu vaccine for children with neurological disorders

Children who have neurological disorders such as cerebral palsy or epilepsy are no more likely to be vaccinated against influenza than youngsters without these conditions, despite the increased risk for complications from flu these children experience. [More]
Seal Shield's new Airocide DS air purifier may help eliminate 'Super Bugs' in hospitals

Seal Shield's new Airocide DS air purifier may help eliminate 'Super Bugs' in hospitals

Seal Shield LLC (Jacksonville, FL), today announced the new Airocide DS air purifier. The Airocide DS is a table top or bed side air purification product that uses a unique photocatalytic biocide reactor to eliminate viral, fungal and bacterial pathogens from the air. Developed by NASA, Airocide converts dangerous bacteria, virus and destructive VOC's into harmless water vapor without producing ozone or other harmful byproducts. [More]
MGH investigators identify inflammatory molecule that plays key role in lupus

MGH investigators identify inflammatory molecule that plays key role in lupus

Massachusetts General Hospital (MGH) investigators have identified an inflammatory molecule that appears to play an essential role in the autoimmune disorder systemic lupus erythematosus, commonly known as lupus. [More]
HPAI H5 viruses of Eurasian origin continue to circulate in North American wild birds

HPAI H5 viruses of Eurasian origin continue to circulate in North American wild birds

Highly pathogenic avian influenza (HPAI) H5 viruses of Eurasian origin continue to circulate and evolve in North American wild birds. [More]
Alere i Strep A test receives marketing clearance from FDA

Alere i Strep A test receives marketing clearance from FDA

Alere Inc., a global leader in rapid diagnostic tests, today announced that its Alere i Strep A test has received marketing clearance from the U.S. Food and Drug Administration. Alere i Strep A is the first molecular test that detects Group A Streptococcus (GAS) bacteria in throat swab specimens in 8 minutes or less. [More]

American scientists develop simple system to detect influenza virus from nasal or throat swabs

Almost every winter sees a new wave of influenza, threatening people by its highly contagious character and severe pathogenesis if those with weak or compromised immune system are infected. But when do sniffing and high temperature only point to a bad cold and when is it real influenza? American scientists have developed a simple system for testing for the influenza virus by just taking nasal or throat swabs and measuring the viral presence amperometrically by assessing the glucose level. [More]
Rare genetic mutation explains why flu can kill in rare cases

Rare genetic mutation explains why flu can kill in rare cases

Nobody likes getting the flu, but for some people, fluids and rest aren't enough. A small number of children who catch the influenza virus fall so ill they end up in the hospital — perhaps needing ventilators to breathe — even while their family and friends recover easily. New research by Rockefeller University scientists, published March 26 in Science, helps explain why: a rare genetic mutation. [More]
Pathogen may cause high levels of virulence in closely-related hosts

Pathogen may cause high levels of virulence in closely-related hosts

When viruses such as influenza and Ebola jump from one species to another, their ability to cause harm can change dramatically, but research from the University of Cambridge shows that it may be possible to predict the virus's virulence by looking at how deadly it is in closely-related species. [More]
New vaccine for post exposure treatment of rabies infection enters human clinical trial

New vaccine for post exposure treatment of rabies infection enters human clinical trial

Yisheng Biopharma Co., Ltd., a biopharmaceutical company focusing on the research, development, manufacturing, sales and marketing of vaccine products, announced that a new vaccine for the post exposure treatment of the rabies infection was entering human clinical trial after a six-year long collaboration with a number of research institutes worldwide. [More]
Flu vaccine based upon four strains of inactivated influenza enhances flu protection

Flu vaccine based upon four strains of inactivated influenza enhances flu protection

A flu vaccine given just under the surface of the skin that includes four strains of inactivated influenza could be more protective than a similar flu vaccine containing only three strains, Saint Louis University research found. [More]
Advertisement
Advertisement